This increase in the fraction of exhaled NO (FENO) in patients with asthma is mainly caused by an increase in the expression and activity of the iNOS enzyme due to pro-inflammatory stimuli: cytokines, oxidants, and other inflammatory mediators. This evidence concerns the gene NOS2 and asthma.